Study sees no eye cancer risk from mobile phones
WASHINGTON (Reuters) - Regular mobile phone use does not appear to increase a person’s risk of getting a type of cancer called melanoma of the eye, German researchers said on Tuesday.
The study involving about 1,600 people detected no link between the time a person spent using a cell phone over about a decade and their chances of developing melanoma of the eye, they wrote in the Journal of the National Cancer Institute.
The findings contradicted an earlier, smaller study by the same researchers that had raised concern about such a link.
Melanoma is an aggressive form of cancer that can spread quickly. It arises in cells that produce the pigment called melanin that gives skin its color. The eyes also have cells that produce melanin. Melanoma of the eye is rare.
The condition also is called uveal melanoma.
The issue of whether long-term use of cell phones can cause cancer, in particular brain tumors, has been a hot topic, but most studies examining the matter have found no such association.
“We did not corroborate our previous results that showed an increased risk of uveal melanoma among regular mobile phone users,” Dr. Andreas Stang of the Martin-Luther-University of Halle-Wittenberg in Germany wrote in the journal.
“Uncertainty exists about the role, if any, of radio waves transmitted by radio sets or mobile phones in human carcinogenesis (cancer development),” they added.
(Reporting by Will Dunham; Editing by Cynthia Osterman)
--------------------------------------------------------------------------------------------Related Posts:
LONDON (Reuters) - Doctors baffled by an unexplained rash on people’s ears or cheeks should be on alert for a skin allergy caused by too much mobile phone use, the British Association of Dermatologists said on Thursday. Citing published studies, the group said a red or itchy rash, known as “mobile phone dermatitis,” affects people who
Full Post: Doctors warn of rash from mobile phone use
--------------------------------------------------------------------------------------------
BRUSSELS (Reuters) - Belgian health products distributor Omega Pharma will launch a chip it claims can counter potentially damaging radiation from mobile phones and has high hopes for its sales. The company, which sells non-prescription products such as wart treatments, pregnancy tests and sun tan lotions to pharmacists, unveiled the E-waves phone chip on Tuesday, a
Full Post: Mobile phone chip to counter radiation unveiled
--------------------------------------------------------------------------------------------
By Megan Rauscher NEW YORK (Reuters Health) - Blocking certain proteins in cells may be a way to attack ovarian cancer, researchers said at the annual meeting of the American Society for Cell Biology underway in San Francisco. For growth and proliferation, ovarian cancer cells are “addicted” to a family of proteins produced by the cancer-promoting gene
Full Post: Possible way to treat ovarian cancer reported
--------------------------------------------------------------------------------------------
By Will Dunham WASHINGTON (Reuters) - Distinctive genetic changes occur in the cancer cells that trigger relapse in patients with the most common type of childhood cancer, according to a study that may offer new hope for beating the disease. Writing in the journal Science on Thursday, the scientists described key genetic differences in cancer cells of
Full Post: Scientists track genetic changes in leukemia
--------------------------------------------------------------------------------------------
CHICAGO (Reuters) - U.S. researchers have found a way to switch on a cell-killing protein in the body, a finding that could lead to new ways to treat diseases like cancer in which cells grow out of control. The body naturally activates this protein, called BAX, to kill off unwanted or defective cells in a process
Full Post: Researchers find trigger for killer protein